drugset / Trial / NCT00485472

Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee

NCT00485472

Phase 2 Terminated 194 enrolled UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to evaluate the effectiveness, safety and tolerability of lacosamide (LCM) 400mg/day in treating the signs and symptoms of osteoarthritis of the knee.

Timeline

Start
2007-03
Primary completion
2007-11
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 400 mg

Indications